Welcome to LookChem.com Sign In|Join Free

CAS

  • or

506-43-4

Post Buying Request

506-43-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

506-43-4 Usage

Description

CIS,CIS-9,12-OCTADECADIENOL, also known as (9Z,12Z)-9,12-Octadecadien-1-ol, is a long chain fatty alcohol derived from linoleyl acid. It is characterized by the presence of two double bonds located at positions 9 and 12, making it the 9Z,12Z-geoisomer of octadecanol. CIS,CIS-9,12-OCTADECADIENOL has been synthesized through transfer hydrogenation using a ruthenium-based catalyst from its parent fatty acid.

Uses

Used in Chemical Synthesis:
CIS,CIS-9,12-OCTADECADIENOL is used as a building block for the synthesis of lipid-based unsymmetrical O,O-dialkylphosphites. Its unique structure and functional groups make it a valuable component in the creation of various chemical compounds and materials.
Used in Pharmaceutical Industry:
CIS,CIS-9,12-OCTADECADIENOL, being a derivative of linoleyl acid, may have potential applications in the pharmaceutical industry due to its structural similarity to fatty acids that are known to have biological activities. Further research and development could lead to the discovery of new drugs or therapeutic agents based on this compound.
Used in Cosmetics Industry:
Given its fatty alcohol nature, CIS,CIS-9,12-OCTADECADIENOL could be utilized in the cosmetics industry as an ingredient in various skincare and hair care products. Its emollient and moisturizing properties may contribute to the development of products that improve skin and hair health.
Used in Research and Development:
The unique structure of CIS,CIS-9,12-OCTADECADIENOL makes it an interesting compound for research and development in various scientific fields. It can be used as a model compound to study the properties and behavior of long chain fatty alcohols and their derivatives, leading to a better understanding of their potential applications and benefits.

Check Digit Verification of cas no

The CAS Registry Mumber 506-43-4 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,0 and 6 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 506-43:
(5*5)+(4*0)+(3*6)+(2*4)+(1*3)=54
54 % 10 = 4
So 506-43-4 is a valid CAS Registry Number.
InChI:InChI=1/C18H34O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19/h6-7,9-10,19H,2-5,8,11-18H2,1H3/b7-6-,10-9-

506-43-4 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • USP

  • (1367647)  Linoleyl alcohol  United States Pharmacopeia (USP) Reference Standard

  • 506-43-4

  • 1367647-5X30MG

  • 4,662.45CNY

  • Detail

506-43-4Relevant articles and documents

-

Allen,J.C.

, p. 906 - 907 (1969)

-

Enantiomeric synthesis of natural alkylglycerols and their antibacterial and antibiofilm activities

Fernández Montoya, Deicy J.,Contreras Jordan, Luis A.,Moreno-Murillo, Bárbara,Silva-Gómez, Edelberto,Mayorga-Wandurraga, Humberto

supporting information, p. 2544 - 2550 (2019/11/13)

Alkylglycerols (AKGs) are bioactive natural compounds that vary by alkyl chain length and degree of unsaturation, and their absolute configuration is 2S. Three AKGs (5l–5n) were synthesised in enantiomerically pure form, and were characterised for the first time together with 12 other known and naturally occurring AKGs (5a–5k, 5o). Their structures were established using 1H and 13C APT NMR with 2D-NMR, ESI-MS or HRESI-MS and optical rotation data, and they were tested for their antibacterial and antibiofilm activities. AKGs 5a–5m and 5o showed activity against five clinical isolates and P. aeruginosa ATCC 15442, with MIC values in the range of 15–125 μg/mL. In addition, at half of the MIC, most of the AKGs reduced S. aureus biofilm formation in the range of 23%–99% and P. aeruginosa ATCC 15442 biofilm formation in the range of 14%–64%. The antibiofilm activity of the AKGs assessed in this work had not previously been studied.

A Supramolecular Strategy for Selective Catalytic Hydrogenation Independent of Remote Chain Length

Bender, Trandon A.,Bergman, Robert G.,Raymond, Kenneth N.,Toste, F. Dean

supporting information, p. 11806 - 11810 (2019/08/22)

Performing selective transformations on complex substrates remains a challenge in synthetic chemistry. These difficulties often arise due to cross-reactivity, particularly in the presence of similar functional groups at multiple sites. Therefore, there is a premium on the ability to perform selective activation of these functional groups. We report here a supramolecular strategy where encapsulation of a hydrogenation catalyst enables selective olefin hydrogenation, even in the presence of multiple sites of unsaturation. While the reaction requires at least one sterically nondemanding alkene substituent, the rate of hydrogenation is not sensitive to the distance between the alkene and the functional group, including a carboxylate, on the other substituent. This observation indicates that only the double bond has to be encapsulated to effect hydrogenation. Going further, we demonstrate that this supramolecular strategy can overcome the inherent allylic alcohol selectivity of the free catalyst, achieving supramolecular catalyst-directed regioselectivity as opposed to directing-group selectivity.

AMPHIPHILE PRODRUGS

-

Page/Page column 0184, (2019/06/12)

Amphiphilic prodrugs of general formula A-X are disclosed, wherein A is a biologically active agent or may be metabolised to a biologically active agent; and X is selected from the group consisting of R, or up to three R moieties attached to a linker, Y1, Y2 or Y3, wherein R is selected from a group consisting of alkyl, alkenyl, alkynyl, branched alkyl, branched alkenyl, branched alkynyl, substituted alkyl, substituted alkenyl and substituted alkynyl groups and their analogues; Y1 is a linker group which covalently attached to an R group at one site and is attached to A at a further independent site; Y2 is a linker group which is covalently attached to two R groups at two independent sites and is attached to A at a further independent site; and Y3 is a linker group which is covalently attached to three R groups at three independent sites and is attached to A at a further independent site. Self-assembly of the amphiphilic prodrugs into reverse lyotropic phases, particularly hexagonal, cubic and sponge, is disclosed. In preferred embodiments A is dopamine or a 5-fluorouracil prodrug.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 506-43-4